A Dose-Escalation Study of ENMD-2076 Administered Orally to Patients With Advanced Cancer
Clinical trial NCT00658671 · COMPLETED
Trial details
- NCT number
- NCT00658671
- Sponsor
- CASI pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2010-12-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.